NZ's A2 Milk To Cancel Synlait's Exclusive Supply Rights On Infant Milk Formula | Old North State Wealth News
Connect with us

US News

NZ’s A2 Milk to cancel Synlait’s exclusive supply rights on infant milk formula



© Reuters. FILE PHOTO: An A2 milk sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 6, 2020. REUTERS/Aly Song/File Photo

(Reuters) – New Zealand’s A2 Milk Company Ltd said on Monday it had given notice to Synlait Milk after market hours on Friday that it was canceling its exclusive manufacturing and supply rights for certain infant milk formula products of company.

A2 Milk issued cancellation notices on Synlait’s exclusive manufacturing and supply rights on stages 1 to 3 of the dairy producer’s infant milk formula as Synlait’s delivery in full and on time performance during fiscal 2023 fell below the required level.

Synlait did not immediately respond to a Reuters request for comment but A2 Milk said the manufacturing and supply agreement between the parties would remain in place as Synlait considers the cancellation notice.

Removal of Synlait’s exclusivity will give the dairy firm a chance to expand production of its English label product at any facility at a time when one of its largest markets, China, introduces stringent regulations for infant formula.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.